We have advised a medical device manufacturer on the regulatory implications of the restriction on synthetic polymer microparticles for its products.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type (2)
Sectors
Expertises
100 results
Newest first
We have advised a start-up on the legal limitations and requirements related to the transport of dangerous substances.
Our team advised a client on the registration process under REACH.
We have advised a healthcare institution on the conditions under which medical professional secrecy may be breached.
We advised a mid-sized company on the qualification of a cosmetic product to facilitate its compliant and effective market launch.
We have guided several clients through notified body interactions and discussions with competent authorities on product classification.
We have supported an IVD manufacturer in the design and conduct of performance studies. We regularly advise clients on post-market performance follow-up (PMPF) obligations.
We have assisted multiple manufacturers with the transition of their legacy IVD Directive products to the IVDR framework.
Our team has advised an IVD-manufacturer on use of the inhouse-exemption under the IVDR.
We have advised an IVD manufacturer on a bringing companion diagnostic to market with respect to a patient support program.